炎症药理学 SCIE

期刊简介估计审稿时候：

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

《炎症药理学》是国际根本和临床药理学结合会 (IUPHAR) 胃肠道分会和匈牙利尝试和临床药理学协会 (HECPS) 的官方出书物。《炎症药理学》颁发有关炎症及其药理学节制各个方面的论文，重点比拟 (a) 差别的炎症状况，和 (b) 用于医治炎症的药物的感化、医治功效和宁静性。炎症范例的比拟方面包含胃肠道疾病（比方溃疡性结肠炎、克罗恩病）、寄生虫病、药物和环境身分影响的毒理学表现、枢纽炎和毁伤或朽迈对骨骼肌的炎症影响。该期刊有七个首要乐趣范畴：

-药物-疾病彼此感化 - 前提药理学 - 即病情（疾病或压力状况）影响抗炎药物的医治反应和副感化（不良反应）。药物-疾病和药物-疾病彼此感化的机制和差别应激状况的感化

-风湿病学 - 出格夸大新药物临床反应功效的丈量体例、抗风湿药物的不良反应

-胃肠病学 - 出格夸大植物和人类模子、粘膜炎症和溃疡的机制和新型和已成立的抗溃疡、抗炎药物或抗寄生虫药物的感化

-神经炎症和痛苦悲伤 - 模子系统、新型麻醉剂的药理学和神经炎症和痛苦悲伤的机制

-新药、自然产品和养分保健品 - 及其对炎症进程的影响，出格是与传统药物（如 NSAID）比拟有新感化形式的迹象

-炎症时代的肌肉-免疫彼此感化 [...]

《Inflammopharmacology》(炎症药理学)编辑部通信体例为PICASSOPLATZ 4, BASEL, SWITZERLAND, 4052。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。